https://doi.org/10.1007/s40477-021-00600-z
R
Rita De Sanctis
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
227
Papers
3.0K
Citations
27
h-index
56
i10-index
Rita De Sanctis is an academic researcher from Humanitas University. The author has contributed to research in topics: Breast Cancer Treatment Studies & HER2/EGFR in Cancer Research & Cancer Immunotherapy and Biomarkers. The author has an h-index of 27, co-authored 193 publications.
ORCID: 0000-0003-3202-1933Papers by this author
worksRole of lung ultrasound for the etiological diagnosis of acute lower respiratory tract infection (ALRTI) in children: a prospective study
2021 · Journal of Ultrasound · 60 citations
Cyclin-dependent kinase 2 (CDK2) inhibitors and others novel CDK inhibitors (CDKi) in breast cancer: clinical trials, current impact, and future directions
2024 · Critical Reviews in Oncology/Hematology · 60 citations
https://doi.org/10.1016/j.critrevonc.2024.104324
Neoadjuvant chemotherapy in hormone receptor-positive/HER2-negative early breast cancer: When, why and what?
2021 · Critical Reviews in Oncology/Hematology · 52 citations
https://doi.org/10.1016/j.critrevonc.2021.103280
Opportunities and Challenges of Synthetic Data Generation in Oncology
2023 · JCO Clinical Cancer Informatics · 35 citations
https://doi.org/10.1200/cci.23.00045
Hope and Hype around Immunotherapy in Triple-Negative Breast Cancer
2023 · Cancers · 20 citations
https://doi.org/10.3390/cancers15112933
HR+/HER2– de novo metastatic breast cancer: a true peculiar entity?
2023 · Drugs in Context · 17 citations
https://doi.org/10.7573/dic.2022-12-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat